Danaher Corp. (DHR): Price and Financial Metrics


Danaher Corp. (DHR): $263.50

0.91 (+0.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DHR POWR Grades


  • Sentiment is the dimension where DHR ranks best; there it ranks ahead of 98.09% of US stocks.
  • DHR's strongest trending metric is Value; it's been moving up over the last 31 weeks.
  • DHR's current lowest rank is in the Momentum metric (where it is better than 15.14% of US stocks).

DHR Stock Summary

  • DHR has a higher market value than 98.9% of US stocks; more precisely, its current market capitalization is $187,299,897,423.
  • Danaher Corp's stock had its IPO on November 5, 1987, making it an older stock than 90.52% of US equities in our set.
  • The volatility of Danaher Corp's share price is greater than that of only 4.62% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Danaher Corp, a group of peers worth examining would be TMO, TMUS, ABT, TXN, and NVO.
  • DHR's SEC filings can be seen here. And to visit Danaher Corp's official web site, go to www.danaher.com.

DHR Price Target

For more insight on analysts targets of DHR, see our DHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $291.74 Average Broker Recommendation 1.4 (Strong Buy)

DHR Stock Price Chart Interactive Chart >

Price chart for DHR

DHR Price/Volume Stats

Current price $263.50 52-week high $263.50
Prev. close $262.59 52-week low $168.59
Day low $263.50 Volume 322
Day high $263.50 Avg. volume 2,562,110
50-day MA $250.76 Dividend yield 0.32%
200-day MA $231.47 Market Cap 187.95B

Danaher Corp. (DHR) Company Bio


Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are "Life Sciences", "Diagnostics", and "Environmental & Applied Solutions". (Source:Wikipedia)

DHR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$263.50$102.75 -59%

We started the process of determining a valid price forecast for Danaher Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Danaher Corp ranked in the 31th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 59.17%. In terms of the factors that were most noteworthy in this DCF analysis for DHR, they are:

  • Interest coverage, a measure of earnings relative to interest payments, is 21.54 -- which is good for besting 78.96% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • DHR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 36.79% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-60%
1%-60%
2%-59%
3%-59%
4%-59%
5%-58%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as DHR, try CRL, GMED, HAPP, NRC, and NVS.


DHR Latest News Stream


Event/Time News Detail
Loading, please wait...

DHR Latest Social Stream


Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Breakout Bonanza: 3 Health Stocks Top Buy Points; Another Inches Up

Health care stocks Intuitive Surgical and Danaher broke out on Monday, as Globus Medical flirted with a buy point.

Yahoo | June 21, 2021

Danaher's (DHR) Aldevron Buyout to Aid Genomic Medicine

Danaher (DHR) to gain from the Aldevron acquisition as it will increase growth opportunities in the genomic medicine field. The acquired assets will be integrated with Danaher's Life Sciences segment.

Yahoo | June 18, 2021

The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx

The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx

Yahoo | June 18, 2021

Danaher (DHR) Moves 5% Higher: Will This Strength Last?

Danaher (DHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Yahoo | June 18, 2021

Danaher Snaps up Aldevron for $9.6B; Shares Spike 5%

Shares of Danaher Corporation (DHR) jumped 5% on June 17 to close at $257.08 after the company inked a deal to acquire privately-held Aldevron in an all-cash transaction for $9.6 billion. Danaher is a global science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Founded in 1998, Aldevron, a manufacturer of high-quality plasmid DNA, mRNA, and proteins, serves biotechnology and pharmaceutical customers across

Yahoo | June 18, 2021

Read More 'DHR' Stories Here

DHR Price Returns

1-mo 4.33%
3-mo 20.18%
6-mo 19.08%
1-year 51.27%
3-year 169.26%
5-year 169.22%
YTD 18.73%
2020 45.34%
2019 49.55%
2018 11.80%
2017 20.01%
2016 -15.65%

DHR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0078 seconds.